BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32986381)

  • 1. LTA, LEP, and TNF-a Gene Polymorphisms are Associated with Susceptibility and Overall Survival of Diffuse Large B-Cell lymphoma in an Arab Population: A Case-Control Study.
    Al-Khatib SM; Abdo N; Al-Eitan LN; Al-Mistarehi AW; Zahran DJ; Kewan TZ
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2783-2791. PubMed ID: 32986381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population.
    Zhang Y; Chen MB; Zhou XY; Hong XN
    PLoS One; 2013; 8(6):e66411. PubMed ID: 23840460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
    Skibola CF; Bracci PM; Nieters A; Brooks-Wilson A; de Sanjosé S; Hughes AM; Cerhan JR; Skibola DR; Purdue M; Kane E; Lan Q; Foretova L; Schenk M; Spinelli JJ; Slager SL; De Roos AJ; Smith MT; Roman E; Cozen W; Boffetta P; Kricker A; Zheng T; Lightfoot T; Cocco P; Benavente Y; Zhang Y; Hartge P; Linet MS; Becker N; Brennan P; Zhang L; Armstrong B; Smith A; Shiao R; Novak AJ; Maynadie M; Chanock SJ; Staines A; Holford TR; Holly EA; Rothman N; Wang SS
    Am J Epidemiol; 2010 Feb; 171(3):267-76. PubMed ID: 20047977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab.
    Yri OE; Ekstrøm PO; Hilden V; Gaudernack G; Liestøl K; Smeland EB; Holte H
    Leuk Lymphoma; 2013 Oct; 54(10):2205-14. PubMed ID: 23391141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of IL-6 and IL-10 Gene Polymorphisms in Diffuse Large B-Cell Lymphoma Risk and Overall Survival in an Arab Population: A Case-Control Study.
    Al-Khatib SM; Abdo N; Al-Eitan LN; Al-Mistarehi AH; Zahran DJ; Kewan TZ
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32046104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
    Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
    PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP.
    Chae YS; Kim JG; Sohn SK; Moon JH; Kim SN; Lee SJ; Park TI; Lee MH
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):571-7. PubMed ID: 19629486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk.
    Gaudet MM; Egan KM; Lissowska J; Newcomb PA; Brinton LA; Titus-Ernstoff L; Yeager M; Chanock S; Welch R; Peplonska B; Trentham-Dietz A; Garcia-Closas M
    Hum Genet; 2007 May; 121(3-4):483-90. PubMed ID: 17216494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations in CTLA-4, TNF-α, and LTA and susceptibility to T-cell lymphoma in a Chinese population.
    Liu J; Liu J; Song B; Wang T; Liu Y; Hao J; Yu J
    Cancer Epidemiol; 2013 Dec; 37(6):930-4. PubMed ID: 24035239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in cytokine genes as prognostic markers in diffuse large B cell lymphoma patients treated with (R)-CHOP.
    Liu D; Wang Y; Dong M; Guan S; Wang Y; Sun H; Wu N; Li S; Bai J; Chen F; Sun D; Jin Y
    Ann Hematol; 2017 Feb; 96(2):227-235. PubMed ID: 27822610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Polymorphism in TNF-α-308 G/A and TNF-β +252 A/G, as Prognostic Biomarker in Breast Cancer Patients among Indian Population.
    Ahmad MM; Parveen F; Akhter N; Siddiqui JA; Shukla NK; Husain SA
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):301-308. PubMed ID: 32102503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of TNF alpha, LT alpha, MDR1 and codon 72 Tp53 gene polymorphisms on multiple myeloma Egyptian patients.
    Hegazi HM; Elghonemy MS; El-Baiomy MA; Soliman EA; Abdel-Hady EK
    Leuk Res; 2022 Jun; 117():106854. PubMed ID: 35594781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint effect of gene-physical activity and the interactions among CRP, TNF-α, and LTA polymorphisms on serum CRP, TNF-α levels, and handgrip strength in community-dwelling elders in Taiwan - TCHS-E.
    Li CI; Li TC; Liao LN; Liu CS; Yang CW; Lin CH; Hsiao JH; Meng NH; Lin WY; Wu FY; Lin CC
    Age (Dordr); 2016 Apr; 38(2):46. PubMed ID: 27056089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of the Genetic Polymorphism in DNA Repair Pathways on Increased Risk of Glioblastoma Multiforme in the Arab Jordanian Population: A Case-Control Study.
    Al-Khatib SM; Abdo N; Al-Eitan LN; Al-Mistarehi AW; Zahran DJ; Al Ajlouni M; Kewan TZ
    Appl Clin Genet; 2020; 13():115-126. PubMed ID: 32606887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism of tumor necrosis factor alpha (TNF-α) and tumor necrosis factor beta (TNF-β) genes and risk of oral pre-cancer and cancer in North Indian population.
    Gupta S; Nigam K; Srivastav RK; Ahmad MK; Mahdi AA; Sanyal S
    Oral Maxillofac Surg; 2022 Mar; 26(1):33-43. PubMed ID: 33779868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with vitiligo.
    Al-Harthi F; Zouman A; Arfin M; Tariq M; Al-Asmari A
    Genet Mol Res; 2013 Jul; 12(3):2196-204. PubMed ID: 23884763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
    Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
    Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis.
    Cao HY; Zou P; Zhou H
    Gene; 2013 May; 519(2):288-94. PubMed ID: 23485354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-α, TNF-β and IL-10 gene polymorphism and association with oral lichen planus risk in Saudi patients.
    Al-Mohaya MA; Al-Harthi F; Arfin M; Al-Asmari A
    J Appl Oral Sci; 2015; 23(3):295-301. PubMed ID: 26221924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.